Literature DB >> 21309938

Comparison of the prognostic accuracy of the sixth and seventh editions of the TNM classification for intrahepatic cholangiocarcinoma.

Dario Ribero1, Gennaro Nuzzo, Marco Amisano, Mariano Tomatis, Alfredo Guglielmi, Stefano Maria Giulini, Luca Aldrighetti, Fulvio Calise, Giorgio Enrico Gerunda, Antonio Daniele Pinna, Lorenzo Capussotti.   

Abstract

BACKGROUND: The seventh TNM edition introduced a new, specific staging structure for intrahepatic cholangiocarcinoma (IHC).
OBJECTIVE: To compare the accuracy of the sixth and the new seventh edition to predict survival after hepatectomy for IHC.
METHODS: In all, 434 consecutive patients who underwent hepatectomy at 16 tertiary-care centres (1990-2008) were identified. End points were overall (OS) and recurrence-free survival (RFS) for both T cohorts and stage strata.
RESULTS: After a median follow-up of 32.4 months, 3- and 5-year OS and RFS estimates were 47.1% and 32.9%, and 26.5% and 19.1%, respectively. Overall, both the editions were statistically significant discriminators of OS and RFS (P < 0.05). However, the survival curves of the new T2a and T2b cohorts appear superimposed. Conversely, the old T2 and T3 cohorts accurately stratify patients into distinct prognostic groups (P < 0.01). The seventh edition does not show monotonicity of gradients (the T4 category demonstrates significantly better OS and RFS compared with T2 patients). The seventh edition stage I and II are significantly different whereas the old stage I and II were not.
CONCLUSIONS: The new seventh edition of the AJCC/UICC Staging System proved to be adequate although further studies are need to confirm its superiority compared with the previous edition.
© 2011 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2011        PMID: 21309938      PMCID: PMC3048972          DOI: 10.1111/j.1477-2574.2010.00271.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  17 in total

1.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.

Authors:  T Patel
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

2.  Primary liver cancer: intrahepatic cholangiocarcinoma emerges from the shadows.

Authors:  Susan Tsai; Hari Nathan; Timothy M Pawlik
Journal:  Updates Surg       Date:  2010-08

3.  Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma.

Authors:  T Uenishi; K Hirohashi; S Kubo; T Yamamoto; O Yamazaki; H Kinoshita
Journal:  Br J Surg       Date:  2001-07       Impact factor: 6.939

4.  A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables.

Authors:  T Okabayashi; J Yamamoto; T Kosuge; K Shimada; S Yamasaki; T Takayama; M Makuuchi
Journal:  Cancer       Date:  2001-11-01       Impact factor: 6.860

5.  Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.

Authors:  Ken Shirabe; Yohei Mano; Akinobu Taketomi; Yuji Soejima; Hideaki Uchiyama; Shinichi Aishima; Hiroto Kayashima; Mizuki Ninomiya; Yoshihiko Maehara
Journal:  Ann Surg Oncol       Date:  2010-02-05       Impact factor: 5.344

Review 6.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

7.  Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.

Authors:  M Ohtsuka; H Ito; F Kimura; H Shimizu; A Togawa; H Yoshidome; M Miyazaki
Journal:  Br J Surg       Date:  2002-12       Impact factor: 6.939

8.  Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes.

Authors:  S Roayaie; J V Guarrera; M Q Ye; S N Thung; S Emre; T M Fishbein; S R Guy; P A Sheiner; C M Miller; M E Schwartz
Journal:  J Am Coll Surg       Date:  1998-10       Impact factor: 6.113

9.  Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.

Authors:  Hauke Lang; Georgios C Sotiropoulos; George Sgourakis; Klaus J Schmitz; Andreas Paul; Philip Hilgard; Thomas Zöpf; Tanja Trarbach; Massimo Malagó; Hideo A Baba; Christoph E Broelsch
Journal:  J Am Coll Surg       Date:  2009-02       Impact factor: 6.113

10.  Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma.

Authors:  Kazuaki Shimada; Tsuyoshi Sano; Yoshihiro Sakamoto; Minoru Esaki; Tomoo Kosuge; Hidenori Ojima
Journal:  World J Surg       Date:  2007-10       Impact factor: 3.282

View more
  10 in total

Review 1.  Surgical treatment for intrahepatic cholangiocarcinoma.

Authors:  Takahiro Uenishi; Takatsugu Yamamoto; Shigekazu Takemura; Shoji Kubo
Journal:  Clin J Gastroenterol       Date:  2014-02-15

2.  Prognostic Impact of Tumor Growth Type on 7th AJCC Staging System for Intrahepatic Cholangiocarcinoma: a Single-Center Experience of 659 Cases.

Authors:  Shin Hwang; Young-Joo Lee; Gi-Won Song; Kwang-Min Park; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2015-03-28       Impact factor: 3.452

3.   Intrahepatic, perihilar and distal cholangiocarcinoma: Management and outcomes.

Authors:  David Waseem; Patel Tushar
Journal:  Ann Hepatol       Date:  2017 Jan-Feb 2017       Impact factor: 2.400

4.  Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience.

Authors:  Shahzad M Ali; Clancy J Clark; Taofic Mounajjed; Tsung-Teh Wu; William S Harmsen; K Marie Reid-Lombardo; Mark J Truty; Michael L Kendrick; Michael B Farnell; David M Nagorney; Florencia G Que
Journal:  HPB (Oxford)       Date:  2014-11-19       Impact factor: 3.647

5.  Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.

Authors:  Michele Simbolo; Matteo Fassan; Andrea Ruzzenente; Andrea Mafficini; Laura D Wood; Vincenzo Corbo; Davide Melisi; Giuseppe Malleo; Caterina Vicentini; Giorgio Malpeli; Davide Antonello; Nicola Sperandio; Paola Capelli; Anna Tomezzoli; Calogero Iacono; Rita T Lawlor; Claudio Bassi; Ralph H Hruban; Alfredo Guglielmi; Giampaolo Tortora; Filippo de Braud; Aldo Scarpa
Journal:  Oncotarget       Date:  2014-05-15

6.  Raf kinase inhibitor protein inhibits cholangiocarcinoma cell metastasis by downregulating matrix metalloproteinase 9 and upregulating tissue inhibitor of metalloproteinase 4 expression.

Authors:  Junji Ma; Junli Shi; Dongqiang Zhao; Lijuan Cheng; Wenbin Wang; Fangfang Li; Xiaoyu Jiang; Huiqing Jiang
Journal:  Oncol Lett       Date:  2014-10-24       Impact factor: 2.967

7.  Comparison of the sixth and the seventh editions of the UICC classification for intrahepatic cholangiocarcinoma.

Authors:  Benjamin Juntermanns; Gernot Maximilian Kaiser; Lena Orth; Henning Reis; Derar Jaradat; Svenja Sydor; Matthias Buechter; Stefan Kasper; Zoltan Mathé; Georgios Charalambos Sotiropoulos; Hideo Andreas Baba; Ali Canbay; Andreas Paul; Christian Dominik Fingas
Journal:  Eur J Med Res       Date:  2018-06-01       Impact factor: 2.175

Review 8.  Carum copticum L.: a herbal medicine with various pharmacological effects.

Authors:  Mohammad Hossein Boskabady; Saeed Alitaneh; Azam Alavinezhad
Journal:  Biomed Res Int       Date:  2014-06-25       Impact factor: 3.411

Review 9.  Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.

Authors:  Rocio I R Macias
Journal:  ISRN Hepatol       Date:  2014-02-16

10.  Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database.

Authors:  Kaelan J Yao; Salma Jabbour; Niyati Parekh; Yong Lin; Rebecca A Moss
Journal:  BMC Gastroenterol       Date:  2016-09-21       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.